MAUDE Adverse Event Report: ETHICON INC. SFX SPI MCRYL+ UNI 18IN 3-0 SA PS1 PR MP; SUTURE, SURGICAL, ABSORBABLE, POLYGLCOLIC ACID

Catalog Number	SXMP1B102
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Unspecified Infection (1930); Fluid Discharge (2686)
Date of Event	09/08/2023
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Trade name - irgacare®.Active ingredient(s) ¿ triclosan.Dosage form ¿ suture/solid/parenteral.Strength ¿ = 2360 g/m.H6 component code: g07002 device not returned.Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Related medwatch reports: 2210968-2023-08817.
Event or Problem Description
It was reported that a patient underwent an elbow surgery for an olecranon fracture on (b)(6) 2023 and barbed suture was used.The surgeon noticed on (b)(6) 2023 that the wound had some fluids coming out.He assumes that it might be a reaction to the barbed suture or the metal implants he used.The patient underwent a re-operation on (b)(6) 2023 to remove the implants.Additional information was requested.
Additional Manufacturer Narrative
Product complaint # (b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information: b3 additional h6 health effect - clinical code additional h6 type of investigation additional information was requested, and the following was obtained: ¿ on what tissue was the suture used? - subcutaneus.¿ what was the tissue condition (normal, thin, calcified, fragile, diseased)? - thin.¿ please describe any medical/surgical intervention required for this suture event including dates and results.- reoperation 9/11/2023 - healed.¿ did the operating surgeon observe any suture deficiency or anomaly before, during, after the suture placement or during any re-operation? - no.¿ was the fixation loop secured to tissue at the initiation of suture use during the index procedure? - yes ¿ was at least one reverse stitch performed prior to closure? - yes ¿ please describe the patient manifestations of the reported reaction (location, severity, appearance, systemic or local reaction).- local: skin and subcutaneous infection (operation area).¿ please provide the onset date/time of the reaction from the initial procedure.- three days prior the second operation.The patient is based outside of attica, and hasn¿t visiting the doctor earlier.¿ other relevant patient history/concomitant medications? - no.¿ were any pre-op cleansing procedures or products changed recently? if yes, please describe.- no.¿ does the patient have a known allergic history to any medical devices, food and/or medication? - no.¿ was allergy testing performed? if so, please describe with results.- no.¿ what is the physician¿s opinion as to the etiology of or contributing factors to this event? - they cannot identify the etiology.¿ what is the patient's current status? - healed-treated ¿ will the product be returned? if so, please provide the return date and tracking information.- it wasn¿t possible to return the suture as it was difficult to separated it from the human tissue.¿ surgeon¿s name?- dr panagiotis giannakopoulos.¿ the scheduled revision surgery, was it performed to explant the titanium implants? or was the revision surgery performed due to the wound secretion? - it was due to the infection.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Corrected information: e1.

• Brand Name: SFX SPI MCRYL+ UNI 18IN 3-0 SA PS1 PR MP
• Common Device Name: SUTURE, SURGICAL, ABSORBABLE, POLYGLCOLIC ACID
• Manufacturer (Section D): ETHICON INC.; 1000 route 202; raritan NJ 08869
• Manufacturer (Section G): ETHICON INC.-SAN LORENZO PR; road 183, km 8.3; san lorenzo PR 00754
• Manufacturer Contact: elba bello ; 1000 route 202; raritan, NJ 08869 ; 9083863534
• MDR Report Key: 18135836
• Report Number: 2210968-2023-08816
• Device Sequence Number: 12402165
• Product Code: GAM
• UDI-Device Identifier: 10705031236615
• UDI-Public: 10705031236615
• Combination Product (Y/N): Y
• Initial Reporter Country: GR
• PMA/510(K) Number: N12159
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2023
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Foreign,Health Professional,User Facility,Company Representative
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date (Section B): 12/22/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 02/28/2025
• Device Catalogue Number: SXMP1B102
• Device Lot Number: TCBCRH
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 11/09/2023
• Supplement Date Received by Manufacturer: 12/05/2023
• Initial Report FDA Received Date: 11/14/2023
• Supplement Report FDA Received Date: 12/22/2023
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 03/10/2023
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Sex: Female